Drug
Total neoadjuvant therapy (TNT)
Total neoadjuvant therapy (TNT) is a pharmaceutical drug with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_2
2
50%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(3)
Completed(1)
Detailed Status
Recruiting2
Not yet recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 22 (66.7%)
N/A1 (33.3%)
Trials by Status
not_yet_recruiting125%
recruiting250%
completed125%
Recent Activity
2 active trials
Showing 4 of 4
not_yet_recruitingphase_2
Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer
NCT07314528
recruitingphase_2
Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.
NCT06940388
completed
AI-Based Prediction of Pathological Response in Rectal Cancer Patients Receiving Total Neoadjuvant Therapy
NCT07049627
recruitingnot_applicable
Systemic Neoadjuvant and Adjuvant Control by Precision Medicine in Rectal Cancer
NCT04842006
Clinical Trials (4)
Showing 4 of 4 trials
NCT07314528Phase 2
Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer
NCT06940388Phase 2
Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.
NCT07049627
AI-Based Prediction of Pathological Response in Rectal Cancer Patients Receiving Total Neoadjuvant Therapy
NCT04842006Not Applicable
Systemic Neoadjuvant and Adjuvant Control by Precision Medicine in Rectal Cancer
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4